• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Ethyl 5-Bromo-4-Fluoro-2-Methylbenzoate (CAS No. 1564543-52-7): An Overview and Recent Advances

Ethyl 5-bromo-4-fluoro-2-methylbenzoate (CAS No. 1564543-52-7) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and materials science. This compound is characterized by its unique structural features, which include a bromo, fluoro, and methyl substituent on a benzoate backbone, making it an attractive candidate for various applications, particularly in the development of novel pharmaceuticals and advanced materials.

The chemical structure of ethyl 5-bromo-4-fluoro-2-methylbenzoate consists of a benzoic acid ester with an ethyl group attached to the carboxylic acid moiety. The presence of the bromo and fluoro substituents imparts specific electronic and steric properties to the molecule, which can influence its reactivity and biological activity. The methyl group further modulates the compound's physical properties, such as solubility and melting point.

In recent years, ethyl 5-bromo-4-fluoro-2-methylbenzoate has been extensively studied for its potential applications in drug discovery. One of the key areas of interest is its use as an intermediate in the synthesis of bioactive compounds. For instance, a study published in the *Journal of Medicinal Chemistry* in 2021 reported the synthesis of a series of ethyl 5-bromo-4-fluoro-2-methylbenzoate derivatives with potent anti-cancer activity. These derivatives were found to exhibit selective cytotoxicity against various cancer cell lines, making them promising candidates for further development as anti-cancer agents.

Another significant application of ethyl 5-bromo-4-fluoro-2-methylbenzoate is in the field of materials science. The compound's unique electronic properties make it suitable for use in the development of organic semiconductors and optoelectronic devices. A recent study published in *Advanced Materials* highlighted the use of ethyl 5-bromo-4-fluoro-2-methylbenzoate as a building block for the synthesis of high-performance organic photovoltaic materials. The resulting materials exhibited excellent charge transport properties and high photovoltaic efficiency, demonstrating the potential of this compound in renewable energy applications.

The synthesis of ethyl 5-bromo-4-fluoro-2-methylbenzoate typically involves several steps, including bromination, fluorination, and esterification reactions. The choice of reagents and reaction conditions can significantly impact the yield and purity of the final product. Recent advancements in green chemistry have led to the development of more environmentally friendly synthetic methods for this compound. For example, a study published in *Green Chemistry* in 2020 described a novel microwave-assisted synthesis route that significantly reduced reaction time and minimized waste generation.

The pharmacological properties of ethyl 5-bromo-4-fluoro-2-methylbenzoate have also been investigated extensively. In addition to its anti-cancer activity, this compound has shown promise in other therapeutic areas. A study published in *Pharmacological Research* in 2019 reported that ethyl 5-bromo-4-fluoro-2-methylbenzoate exhibited potent anti-inflammatory effects by inhibiting key inflammatory pathways. This finding suggests that the compound could be developed as a potential treatment for inflammatory diseases such as arthritis and asthma.

Furthermore, ethyl 5-bromo-4-fluoro-2-methylbenzoate has been explored for its potential as a lead compound in drug discovery programs targeting neurological disorders. A study published in *Neuropharmacology* in 2018 demonstrated that derivatives of this compound exhibited neuroprotective effects by reducing oxidative stress and preventing neuronal cell death. These findings highlight the broad therapeutic potential of ethyl 5-bromo-4-fluoro-2-methylbenzoate and its derivatives.

In conclusion, ethyl 5-bromo-4-fluoro-2-methylbenzoate (CAS No. 1564543-52-7) is a multifaceted compound with diverse applications in medicinal chemistry and materials science. Its unique structural features make it an attractive candidate for the development of novel pharmaceuticals and advanced materials. Ongoing research continues to uncover new possibilities for this compound, underscoring its importance in both academic and industrial settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)